
准确,让病变无所遁形
可及,让筛查触手可及
无创,让女性从容安心
以甲基化创新,让妇科肿瘤早筛惠及每一位女性。
三大核心产品,覆盖妇科三大恶性肿瘤
基于 DNA 甲基化的无创早筛早诊产品,针对宫颈癌、子宫内膜癌、卵巢癌提供精准检测方案。
以循证数据,铸就专业信赖
循证为基,持续创新
开展多项前瞻性多中心临床试验,发表多篇学术文献,以循证依据推动甲基化应用。

Effectiveness analysis and clinical application potential exploration of combined detection of PAX1/JAM3 gene methylation in early diagnosis of cervical precancerous lesions
期刊:Clinical Epigenetics
发表单位:Tumor Hospital Affiliated to Xinjiang Medical University
DOI: 10.1186/s13148-026-02095-z

CDO1 and CELF4 methylation assay as the dominant predictor of endometrial cancer: A cohort analysis across pre- and post-menopausal cohorts
期刊:Gynecologic Oncology
发表单位:Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University)
DOI: 10.1016/j.ygyno.2026.01.776

DNA methylation detection is a significant biomarker for screening endometrial cancer in premenopausal women with abnormal uterine bleeding
期刊:International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society
发表单位:the Third Xiangya Hospital, Central South University
DOI: 10.1136/ijgc-2024-005723

Effectiveness analysis and clinical application potential exploration of combined detection of PAX1/JAM3 gene methylation in early diagnosis of cervical precancerous lesions
期刊:Clinical Epigenetics
发表单位:Tumor Hospital Affiliated to Xinjiang Medical University
DOI: 10.1186/s13148-026-02095-z

CDO1 and CELF4 methylation assay as the dominant predictor of endometrial cancer: A cohort analysis across pre- and post-menopausal cohorts
期刊:Gynecologic Oncology
发表单位:Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University)
DOI: 10.1016/j.ygyno.2026.01.776

DNA methylation detection is a significant biomarker for screening endometrial cancer in premenopausal women with abnormal uterine bleeding
期刊:International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society
发表单位:the Third Xiangya Hospital, Central South University
DOI: 10.1136/ijgc-2024-005723
获多项指南与共识推荐
多部国家级临床指南与专家共识支持产品在临床上的规范化应用。






























